Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1988-11-8
|
pubmed:abstractText |
The efficacy and tolerability of defibrotide (800 mg/i.v.) and calcium heparin (15,000 UI/s.c.) in the prophylaxis of post-surgical deep venous thrombosis (DVT) and pulmonary embolism (PE) were compared in a multicentre trial involving 60 Italian surgical institutions (general surgery, obstetrics and gynecology, urology). Total enrollment was 2,250 patients (defibrotide: 1.194; calcium heparin 1.056). According to the protocol, the clinical suspicion of DVT and/or PE led to in-depth diagnostic evaluations (DVT: Doppler ultrasound velocimetry; PE: chest X-rays; ECG, pulmonary scintigraphic scanning). The incidence of post-surgical DVT was similar in the two groups (defibrotide: 8 patients; calcium heparin: 10 patients). A trend towards a lower incidence of DVT in the defibrotide group no PE; calcium heparin: 4 cases (chi 2 = 4.530, p less than 0.05). The local and systemic tolerability of both treatment was excellent. This trial, carried out in routine surgical practice, establishes the profibrinolytic approach to DVT prophylaxis as a sound and effective alternative to the traditional interference with the coagulation cascade.
|
pubmed:language |
ita
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Fibrinolytic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Heparin,
http://linkedlifedata.com/resource/pubmed/chemical/Polydeoxyribonucleotides,
http://linkedlifedata.com/resource/pubmed/chemical/calcium heparin,
http://linkedlifedata.com/resource/pubmed/chemical/defibrotide
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0026-4806
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
79
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
783-90
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3050616-Analysis of Variance,
pubmed-meshheading:3050616-Clinical Trials as Topic,
pubmed-meshheading:3050616-Female,
pubmed-meshheading:3050616-Fibrinolytic Agents,
pubmed-meshheading:3050616-Heparin,
pubmed-meshheading:3050616-Humans,
pubmed-meshheading:3050616-Male,
pubmed-meshheading:3050616-Middle Aged,
pubmed-meshheading:3050616-Multicenter Studies as Topic,
pubmed-meshheading:3050616-Polydeoxyribonucleotides,
pubmed-meshheading:3050616-Postoperative Complications,
pubmed-meshheading:3050616-Pulmonary Embolism,
pubmed-meshheading:3050616-Random Allocation,
pubmed-meshheading:3050616-Thrombophlebitis
|
pubmed:year |
1988
|
pubmed:articleTitle |
[Comparative study of defibrotide and calcium heparin in the prevention of postoperative deep venous thrombosis. A randomized multicenter study].
|
pubmed:affiliation |
Servizio Medico di Farmacovigilanza, Roussel Maestretti, Milano.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
English Abstract,
Randomized Controlled Trial,
Multicenter Study
|